persulphates have been identified as the cause of occupational asthma in hairdressers. Also employees in persulphate production with occupational asthma have been described. It was the aim of this study to give an estimate of the prevalence of asthma due to persulphates in chemical workers with exposure to ammonium and sodium persulphate. Methods-A cross sectional study was performed in 32 of 33 employees of a persulphate producing chemical plant. Eighteen of 23 workmen from the same plant with no exposure to persulphates were taken as controls. Also, information was collected from medical records of the seven subjects who had left the persulphate production for medical reasons since 1971. Data were recalled by a questionnaire, skin prick tests were performed with five environmental allergens, and ammonium and sodium persulphate (80 mg/ml). Specific immunoglobulin E (IgE) to the same environmental allergens as in the skin test, and total IgE were measured. Lung function and bronchial responsiveness to histamine were assessed by standard procedures. Workplace concentrations of ammonium and sodium persulphate were estimated by area and personal monitoring. The amount of persulphate was analysed as sulphur by inductively coupled plasma emission spectrometry. Results-Work related rhinitis was reported by one subject with exposure to persulphates, conjunctivitis and bronchitis were reportedly related to work by two controls. There were no cutaneous reactions to persulphates in either group. Four non-atopic subjects exposed to persulphates, and two controls, one atopic and one non-atopic, were considered to be hyperresponsive to histamine. Three subjects exposed to persulphates with bronchial hyperresponsiveness (provocation dose of histamine causing a 15% fall in forced expiratory volume in one second (PD15 FEVy) <t 1 mg) did not show variability in peak expiratory flow of > 20%, the rest refused peak flow measurements. None of the variables showed significant differences between the groups (P > 0.05). 
Methods

SUBJECTS
Sixty nine people had been employed in per-sulphate production since 1971. Thirty six of them had left the workplace before the cross sectional examination. From the medical records of the medical department of the plant, seven subjects left because of suspected allergy to persulphates, the rest for technical reasons. We examined 32 out of 33 present employees (31 male, one female) of the persulphate producing division of the plant. One subject refused to be examined. Six subjects did not allow the histamine challenge. Twenty three workmen without any contact with persulphates were recruited as controls. These controls worked in different areas of the plant and reported qualitatively and quantitatively varying exposure to irritants, mainly welding fumes. Eighteen out of 23 control workmen participated in the study; three refused to have the tests, two were not available, and three people refused the inhalation of histamine. One of four subjects exposed to persulphates with bronchial hyperresponsiveness refused peak flow measurements.
EXWORKERS
Information concerning subjects who had left work in the persulphate division before the present study was collected from both the administration and the medical department plants'. If subjects had to leave for medical reasons, symptoms and signs were documented in the medical records. Thirty six subjects had left the persulphate workshop since 1971, among them seven workers left for medical reasons. Six of these left because of work related skin disease without symptoms of asthma, the other had complained of asthma. Immunological assessments or lung function tests for these workers were not available.
RECALLED DATA
Age and occupational exposure time were recorded. Further data were assessed by questionnaire: (a) symptoms of asthma, rhinitis, conjunctivitis, dermatitis, or bronchitis occurring during employment; (b) relation of these symptoms to work; (c) personal and family history of asthma or allergy mediated by immunoglobulin E (IgE), mostly pollinosis or mite allergy confirmed by a physician before employment; (d) wheeze during the previous 12 months; (e) cough at night during the previous 12 months; (f) shortness of breath at night during the previous 12 months; (g) smoking habit (exsmoker, non-smoker, smoker); (h) personal estimate of persulphate exposure (period of occupation at the bagging plant compared with the other workers (low, moderate, high)).
SKIN PRICK TEST
Skin prick tests were performed with common environmental allergens (cat dander, grass, and birch pollens, Dermatophagoides pteronyssinus, and Alternaria tennis (Allergopharma, Reinbek, Germany)). Skin prick tests with persulphates were performed with 80 mg/ml solutions of sodium persulphate (pH 3 9) and ammonium persulphate (pH 3a 1). These solutions were prepared with distilled water, and because of the acidity of the solutions also with phosphate buffer, pH 7-4. The solutions were stored for a maximum of three days at 4VC. Tests 
Sodium persulphate 0-8 (0 3-3 6) 0 9 (0-3-1-3) (n = 9) (n = 4) (table 2) . Other demographic data were not different between groups. Work related symptoms of rhinitis were reported by one subject with exposure to persulphates, and work related conjunctivitis and bronchitis by two controls.
Neither exposed subjects nor controls showed an early or late skin test reaction with persulphates. Sensitisations to environmental allergens as assessed by skin test, EAST, or a combination of both were not different between groups (table 3) . Lung function (FEVy and MEF5,), total IgE, and the dose response slopes of the histamine challenges were not different between groups (figure). The FEV, was < 80% of the predicted value in two subjects exposed to persulphates, and in two controls. Bronchial hyperresponsiveness was present in four (13%) non-atopic persulphate workers, and in two (1 1 %) controls, one atopic and one non-atopic. Peak expiratory flow records of three subjects with bronchial hyperresponsiveness and persulphate exposure showed no significant variability and did not show a trend for lower values associated with working periods, the fourth subject refused peak flow recording. sponsiveness. There is evidence that hyperresponsiveness to non-specific stimuli is present in asthma induced by persulphates.'3 However, sensitivity of methacholine testing may be lower in this type of asthma as one subject without bronchial hyperresponsiveness but with clear immediate asthma after inhalation of bleach powder has been reported.' The number of subjects with bronchial hyperresponsiveness or reduced FEV, among exposed workers of our study was low, and subjects with bronchial hyperresponsiveness did not show reductions in peak flow associated with work. Sensitivity of peak flow measurements might have been increased by performing measurements more than three times daily. As the workers were without any further sign of occupational asthma, peak flow recording three times daily was considered to be a compromise between reliable measurements and sensitivity. Specificity of histamine tests for the detection of (occupational) asthma is low, thus four subjects (13%) with bronchial hyperresponsiveness, but without atopy in the exposed group compared with two subjects (1 1 %) in the control group do not argue for a causal effect of persulphates.
No positive skin prick test reactions with persulphates were detected. However, there is evidence that sensitivity of skin prick tests in the detection of asthma induced by persulphate is low.' 5 False negative skin tests seem not to be important in the present study. No subject with occupational asthma was identified by the synopsis of symptoms, FEV, and bronchial hyperresponsiveness.
The workers clearly had a high degree of exposure to persulphates. Workplace measurements showed concentrations of about 1 mg/M3 for sodium and ammonium persulphate, with little variability between the measurements. We are not aware of any scientific literature reporting persulphate concentrations in the workplace.
In summary, this study did not show a risk of occupational asthma in response to persulphate exposure in highly exposed workers in the chemical industry. Contact dermatitis due to persulphates was frequent in bakers when persulphates were used as baking additives,8 and sensitisation to persulphates among hairdressers with dermatitis was found in 11-3% and 24-5% of the subjects tested.9 10 The difference of these findings from those of the present study may be explained by direct skin contact of bakers and hairdressers with the persulphates, whereas the chemical workers were protected by gloves. However, a moderate risk of contact dermatitis for chemical workers can be assumed as several subjects had to leave the persulphate workshop because of dermatitis.
It is difficult to draw definite conclusions from cross sectional studies. The persulphate workers were older and had been employed longer than the controls. This may be explained by a selection of the controls, as older workmen are more likely to report persulphate exposure than newly employed subjects simply due to longer occupational exposure time. We cannot exclude that selected populations were examined. However, when the medical records of exworkers from the past 20 years were included in the evaluation, our study gives strong evidence that the allergenic, toxic, or irritant potential of persulphates to cause asthma is low, at least in the chemical industry with pure exposure to ammonium or sodium persulphate in the range of 1 mg/mi.
